Literature DB >> 12857774

Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Edwin S Van Amersfoort1, Theo J C Van Berkel, Johan Kuiper.   

Abstract

Bacterial sepsis and septic shock result from the overproduction of inflammatory mediators as a consequence of the interaction of the immune system with bacteria and bacterial wall constituents in the body. Bacterial cell wall constituents such as lipopolysaccharide, peptidoglycans, and lipoteichoic acid are particularly responsible for the deleterious effects of bacteria. These constituents interact in the body with a large number of proteins and receptors, and this interaction determines the eventual inflammatory effect of the compounds. Within the circulation bacterial constituents interact with proteins such as plasma lipoproteins and lipopolysaccharide binding protein. The interaction of the bacterial constituents with receptors on the surface of mononuclear cells is mainly responsible for the induction of proinflammatory mediators by the bacterial constituents. The role of individual receptors such as the toll-like receptors and CD14 in the induction of proinflammatory cytokines and adhesion molecules is discussed in detail. In addition, the roles of a number of other receptors that bind bacterial compounds such as scavenger receptors and their modulating role in inflammation are described. Finally, the therapies for the treatment of bacterial sepsis and septic shock are discussed in relation to the action of the aforementioned receptors and proteins.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12857774      PMCID: PMC164216          DOI: 10.1128/CMR.16.3.379-414.2003

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  599 in total

1.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

2.  Dephosphorylation of endotoxin by alkaline phosphatase in vivo.

Authors:  K Poelstra; W W Bakker; P A Klok; J A Kamps; M J Hardonk; D K Meijer
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

3.  Lymph of patients with a systemic inflammatory response syndrome inhibits lipopolysaccharide-induced cytokine production.

Authors:  L C Lemaire; J J van Lanschot; T van der Poll; W A Buurman; S J van Deventer; D J Gouma
Journal:  J Infect Dis       Date:  1998-09       Impact factor: 5.226

4.  Scavenger receptors are present on rabbit aortic endothelial cells in vivo.

Authors:  A Daugherty; J A Cornicelli; K Welch; S M Sendobry; D L Rateri
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-11       Impact factor: 8.311

Review 5.  Pathogenetic mechanisms of septic shock.

Authors:  J E Parrillo
Journal:  N Engl J Med       Date:  1993-05-20       Impact factor: 91.245

6.  Novel engagement of CD14 and multiple toll-like receptors by group B streptococci.

Authors:  P Henneke; O Takeuchi; J A van Strijp; H K Guttormsen; J A Smith; A B Schromm; T A Espevik; S Akira; V Nizet; D L Kasper; D T Golenbock
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

7.  Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group.

Authors:  S M Opal; C J Fisher; J F Dhainaut; J L Vincent; R Brase; S F Lowry; J C Sadoff; G J Slotman; H Levy; R A Balk; M P Shelly; J P Pribble; J F LaBrecque; J Lookabaugh; H Donovan; H Dubin; R Baughman; J Norman; E DeMaria; K Matzel; E Abraham; M Seneff
Journal:  Crit Care Med       Date:  1997-07       Impact factor: 7.598

8.  Novel signal transduction pathway utilized by extracellular HSP70: role of toll-like receptor (TLR) 2 and TLR4.

Authors:  Alexzander Asea; Michael Rehli; Edith Kabingu; Jason A Boch; Olivia Bare; Philip E Auron; Mary Ann Stevenson; Stuart K Calderwood
Journal:  J Biol Chem       Date:  2002-02-08       Impact factor: 5.157

9.  Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats.

Authors:  S J De Kimpe; M L Hunter; C E Bryant; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-03       Impact factor: 8.739

10.  Increased organ blood flow in chronic endotoxemia is reversed by nitric oxide synthase inhibition.

Authors:  J Meyer; F Hinder; J Stothert; L D Traber; D N Herndon; J T Flynn; D L Traber
Journal:  J Appl Physiol (1985)       Date:  1994-06
View more
  186 in total

1.  Characterization of the apoLp-III/LPS complex: insight into the mode of binding interaction.

Authors:  Merve Oztug; Daisy Martinon; Paul M M Weers
Journal:  Biochemistry       Date:  2012-07-25       Impact factor: 3.162

2.  An MD2-derived peptide promotes LPS aggregation, facilitates its internalization in THP-1 cells, and inhibits LPS-induced pro-inflammatory responses.

Authors:  Anshika Tandon; Munesh Kumar Harioudh; Nayab Ishrat; Amit Kumar Tripathi; Saurabh Srivastava; Jimut Kanti Ghosh
Journal:  Cell Mol Life Sci       Date:  2018-01-08       Impact factor: 9.261

3.  Schizandrin B protects LPS-induced sepsis via TLR4/NF-κB/MyD88 signaling pathway.

Authors:  Jianjun Xu; Caijiao Lu; Zhengjun Liu; Peng Zhang; Hailei Guo; Tingting Wang
Journal:  Am J Transl Res       Date:  2018-04-15       Impact factor: 4.060

4.  Regulation of TLR4-mediated signaling by IBP/Def6, a novel activator of Rho GTPases.

Authors:  Qinzhong Chen; Sanjay Gupta; Alessandra B Pernis
Journal:  J Leukoc Biol       Date:  2008-12-12       Impact factor: 4.962

5.  TLR-4 mediated group IVA phospholipase A(2) activation is phosphatidic acid phosphohydrolase 1 and protein kinase C dependent.

Authors:  Andrej Grkovich; Aaron Armando; Oswald Quehenberger; Edward A Dennis
Journal:  Biochim Biophys Acta       Date:  2009-02-20

Review 6.  Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues.

Authors:  Aileen F B White; Alexei V Demchenko
Journal:  Adv Carbohydr Chem Biochem       Date:  2014       Impact factor: 12.200

7.  Quantitative proteome analysis of human plasma following in vivo lipopolysaccharide administration using 16O/18O labeling and the accurate mass and time tag approach.

Authors:  Wei-Jun Qian; Matthew E Monroe; Tao Liu; Jon M Jacobs; Gordon A Anderson; Yufeng Shen; Ronald J Moore; David J Anderson; Rui Zhang; Steve E Calvano; Stephen F Lowry; Wenzhong Xiao; Lyle L Moldawer; Ronald W Davis; Ronald G Tompkins; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2005-03-07       Impact factor: 5.911

8.  Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.

Authors:  Kimberly L Fife; Yingmei Liu; Kara R Schmelzer; Hsing-Ju Tsai; In-Hae Kim; Christophe Morisseau; Bruce D Hammock; Deanna L Kroetz
Journal:  J Pharmacol Exp Ther       Date:  2008-09-24       Impact factor: 4.030

9.  Changes in macrophage phenotype after infection of pigs with Haemophilus parasuis strains with different levels of virulence.

Authors:  Mar Costa-Hurtado; Alexandre Olvera; Verónica Martinez-Moliner; Nuria Galofré-Milà; Paloma Martínez; Javier Dominguez; Virginia Aragon
Journal:  Infect Immun       Date:  2013-04-15       Impact factor: 3.441

Review 10.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.